JOURNAL OF CLINICAL APHERESIS

Scope & Guideline

Unveiling Breakthroughs in Apheresis for Tomorrow's Healthcare

Introduction

Explore the comprehensive scope of JOURNAL OF CLINICAL APHERESIS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF CLINICAL APHERESIS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0733-2459
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1982 to 2024
AbbreviationJ CLIN APHERESIS / J. Clin. Apheresis
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The Journal of Clinical Apheresis primarily focuses on the advancement and application of apheresis techniques in clinical settings, emphasizing their therapeutic potential across a range of medical conditions. The journal serves as a platform for sharing innovative research, clinical studies, and reviews that inform best practices and enhance patient outcomes in apheresis medicine.
  1. Therapeutic Apheresis Techniques:
    The journal highlights various therapeutic apheresis methods, including therapeutic plasma exchange, leukapheresis, and immunoadsorption, focusing on their clinical applications for conditions such as autoimmune diseases, hematologic disorders, and organ transplant management.
  2. Clinical Outcomes and Efficacy:
    Research articles often evaluate the efficacy, safety, and clinical outcomes associated with different apheresis procedures, providing evidence-based insights that guide clinical practice and improve patient care.
  3. Innovations in Apheresis Technology:
    The journal explores advancements in apheresis technology, including new devices and techniques that enhance the efficiency and safety of procedures, thus contributing to the evolution of apheresis in clinical settings.
  4. Patient-Centered Care:
    Emphasis is placed on understanding patient experiences, tolerability, and outcomes related to apheresis treatments, aiming to improve the overall quality of care for patients undergoing these procedures.
  5. Interdisciplinary Collaboration:
    The journal promotes interdisciplinary research and collaboration among clinicians, researchers, and technologists in the field of apheresis, recognizing the importance of diverse perspectives in advancing the field.
The Journal of Clinical Apheresis reflects dynamic trends in research and clinical practice, with emerging themes that align with current healthcare challenges and advancements in medical technology. These trends indicate a proactive approach to addressing contemporary issues in apheresis medicine.
  1. COVID-19 Related Apheresis Applications:
    Recent publications increasingly focus on the use of therapeutic apheresis in managing complications related to COVID-19, including the treatment of cytokine storms and the effectiveness of convalescent plasma therapy.
  2. Personalized Apheresis Approaches:
    There is a growing trend towards personalized apheresis approaches tailored to individual patient profiles, including genetic and immunological factors, enhancing the efficacy and safety of treatments.
  3. Pediatric Apheresis Innovations:
    An increasing number of studies are dedicated to pediatric apheresis, addressing unique challenges and innovations in performing apheresis in younger populations, which is crucial for optimizing care in this vulnerable group.
  4. Integration of Apheresis with Other Therapies:
    Emerging research explores the integration of apheresis with other therapeutic modalities, such as immunotherapy and targeted therapies, to enhance treatment outcomes for complex conditions.
  5. Long-Term Outcomes and Quality of Life Studies:
    There is a rising emphasis on studies that assess long-term outcomes and quality of life for patients undergoing apheresis, reflecting a broader focus on holistic patient care and post-treatment follow-up.

Declining or Waning

While the Journal of Clinical Apheresis continues to explore a wide range of topics, certain themes have shown signs of declining interest or decreased publication frequency. This shift may reflect evolving clinical practices, emerging technologies, or changes in research funding and focus areas.
  1. Traditional Hemapheresis Techniques:
    There has been a noticeable decline in studies focused on traditional hemapheresis methods, as newer technologies and techniques gain prominence in clinical practice, leading to reduced interest in established methods.
  2. Generalized Apheresis Protocols:
    The publication of generic apheresis protocols without specific clinical context or outcomes has decreased, suggesting a shift towards more tailored and condition-specific research.
  3. Single-Center Studies:
    There appears to be a waning emphasis on single-center studies, with a preference for multicenter collaborations that provide more robust data and insights applicable across diverse clinical settings.
  4. Basic Research on Apheresis Mechanisms:
    Research focusing solely on the basic mechanisms of apheresis without direct clinical application or implications is less frequently published, as the journal prioritizes studies that demonstrate clear clinical relevance.

Similar Journals

Ochsner Journal

Empowering healthcare through open-access insights.
Publisher: OCHSNER CLINICISSN: 1524-5012Frequency: 4 issues/year

Ochsner Journal is a distinguished scholarly publication dedicated to advancing the field of medicine, with a focus on innovative research, clinical practice, and education. Published by OCHSNER CLINIC in the United States, this open-access journal has been a pivotal platform for medical professionals since its inception in 1999. With an ISSN of 1524-5012 and an E-ISSN of 2831-4107, the journal fosters a collaborative environment for the dissemination of groundbreaking studies and insights across various medical disciplines. Notably, in the 2023 Scopus rankings, it holds a commendable position, ranked #234 out of 636 in the General Medicine category, placing it in the 63rd percentile for quality and impact. Spanning multiple converged years, the journal encourages contributions that align with its objective to enhance patient care and promote evidence-based practice. With its open-access model, the Ochsner Journal ensures that its research is readily available to a global audience, thus supporting education and knowledge-sharing within the academic and clinical communities.

British Journal of Pain

Advancing the Science of Pain Management
Publisher: SAGE PUBLICATIONS LTDISSN: 2049-4637Frequency: 4 issues/year

The British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.

Plasmatology

Fostering Collaboration in Plasma Research
Publisher: SAGE PUBLICATIONS LTDISSN: 2634-8535Frequency: 1 issue/year

Plasmatology, published by SAGE Publications Ltd, is a pioneering open-access journal devoted to the field of hematology, focusing on the latest advancements and research in plasma science and its applications. Established in 2021, this journal aims to foster knowledge exchange among researchers, practitioners, and students by providing a platform for sharing innovative studies and reviews. While currently positioned in the Q4 quartile for hematology and ranking #111 in the Scopus database, Plasmatology is dedicated to enhancing its influence and reflecting the dynamic nature of hematological research. With access options freely available to all, the journal encourages a collaborative approach to address the challenges and developments in the field. Based in the United Kingdom, Plasmatology is an emerging resource for anyone interested in advancing their understanding and involvement in plasma research.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Enhancing therapeutic outcomes with groundbreaking insights.
Publisher: SAGE PUBLICATIONS LTDISSN: 1078-1552Frequency: 8 issues/year

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, published by SAGE PUBLICATIONS LTD, is a pivotal resource in the fields of oncology, pharmacology, and medicine, with a dedicated focus on the evolving discipline of oncology pharmacy. Based in the United Kingdom, this journal has been diligently serving its readers since 1995 and continues to explore the intersection of pharmaceutical care and cancer treatment, showcasing innovative practices, research findings, and clinical advancements that are indispensable for healthcare professionals, researchers, and students alike. Although not an open-access journal, it holds a respectable Category Quartile Q3 ranking across its various fields, including Medicine, Oncology, and Pharmacology, indicating its relevance in nurturing academic discourse and addressing critical issues in cancer care. With an ISSN of 1078-1552 and E-ISSN of 1477-092X, the journal invites contributions that enhance the understanding of pharmaceutical interventions in oncology, aiming to improve therapeutic outcomes and patient care. Join a global community of professionals committed to excellence in oncology pharmacy practice and stay informed with cutting-edge research and reviews that significantly impact patient healthcare strategies.

ANNALS OF CLINICAL AND LABORATORY SCIENCE

Connecting Researchers and Practitioners in Health Science
Publisher: ASSOC CLINICAL SCIENTISTSISSN: 0091-7370Frequency: 6 issues/year

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

Therapeutic Advances in Psychopharmacology

Pioneering Insights for Psychological Well-being
Publisher: SAGE PUBLICATIONS LTDISSN: 2045-1253Frequency: 1 issue/year

Therapeutic Advances in Psychopharmacology is a leading open-access journal published by SAGE Publications Ltd, focusing on the dynamic integration of pharmacological therapies and psychological health. Since its inception in 2011, this journal has made a significant impact on the fields of pharmacology and psychiatry, consistently earning a Q1 ranking in both categories as of 2023, reflecting its esteemed position within the scientific community. With an impressive Scopus rank placing it in the top 15% across relevant disciplines, the journal serves as a vital platform for researchers, professionals, and students eager to explore cutting-edge advancements in psychopharmacology. The open-access model, established in 2019, ensures that groundbreaking research is accessible to a wide audience, fostering collaboration and innovation in therapeutic strategies for mental health disorders. Through the dissemination of high-quality research and reviews, Therapeutic Advances in Psychopharmacology is committed to advancing understanding and practice within this critical field.

Pain Management

Elevating Standards in Anesthesiology and Pain Medicine.
Publisher: FUTURE MEDICINE LTDISSN: 1758-1869Frequency: 12 issues/year

Pain Management, published by Future Medicine Ltd, is a premier journal that serves the fields of anesthesiology, pain medicine, and dentistry. With its ISSN 1758-1869 and E-ISSN 1758-1877, this journal is committed to advancing knowledge and practice through high-quality research articles, clinical studies, and expert reviews. The journal has established itself as a pivotal resource in pain management with a commendable impact factor and recognition in category quartiles, achieving Q2 rankings in Anesthesiology and Pain Medicine, as well as in miscellaneous Medicine and Dentistry categories as of 2023. Researchers and professionals will find a wealth of information in its comprehensive articles, which are essential for staying at the forefront of developments in pain management therapies and techniques. Although access is not open, the journal is recognized for its rigor and significance in shaping the future of pain management practices globally. Join the community of experts engaging in cutting-edge discussions by exploring the impactful research being published in this essential resource.

KOREAN JOURNAL OF INTERNAL MEDICINE

Advancing Internal Medicine Knowledge in Korea and Beyond
Publisher: KOREAN ASSOC INTERNAL MEDICINEISSN: 1226-3303Frequency: 6 issues/year

Korean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.

TRANSFUSION AND APHERESIS SCIENCE

Empowering Research for Enhanced Patient Outcomes in Hematology
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.

Indian Journal of Respiratory Care

Connecting Experts to Transform Respiratory Care
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.